Mohamad Fakhreddine, MD

Mohamad Fakhreddine, MD
Mohamad Fakhreddine, MD

Clinical Assistant Professor, Department of Medical Education

Biosketch

Mohamad Fakhreddine, MD is a radiation oncologist at West Michigan Cancer Center. He graduated from Baylor College of Medicine in Houston, Texas and completed his residency in radiation oncology at the University of Texas Health Science Center in San Antonio. He joined the faculty as Assistant Professor at UT Health San Antonio MD Anderson Cancer Center in 2018 and held the position of Assistant Program Director. He was also the local principal investigator of a clinical trial investigating the treatment of oligometastatic cancers. His clinical, teaching, and research interests include general oncology with a focus on the application of radiotherapy to treat head and neck cancers, breast cancer, central nervous system cancers, skin cancers, and oligometastatic cancer.

  • Education and Training
    • Chief Resident 2018, Radiation Oncology, The University of Texas Health Science Center at San Antonio
    • Residency 2016, Radiation Oncology, The University of Texas Health Science Center at San Antonio
    • Internship 2014, Internal Medicine, Medstar Union Memorial Hospital
    • MD 2013, Baylor College of Medicine
    • BS 2007, Mechanical Engineering, The University of Texas at Austin

  • Research
    • radiation side effects
    • oligometastatic cancer
    • central nervous system cancer
    • Skin Cancer
    • Head and Neck Cancers
    • Breast Cancer

  • Publications

    • Sivabhaskar S., Li R., Roy A., Kirby N., Fakhreddine M., Papanikolaou N. Journal of Applied Clinical Medical Physics. 2022;23(8)

    • Bice N., Fakhreddine M., Li R., Nguyen D., Kabat C., Myers P., Papanikolaou N., Kirby N. Physics in Medicine and Biology. 2021;66(21)

    • Bice N., Kirby N., Li R., Nguyen D., Bahr T., Kabat C., Myers P., Papanikolaou N., Fakhreddine M. Journal of Applied Clinical Medical Physics. 2021;22(8):105-119.

    • Li R., Roy A., Bice N., Kirby N., Fakhreddine M., Papanikolaou N. Medical Physics. 2021;48(9):5152-5164.

    • Ridge N.A., Agarwal M.S., Fakhreddine M.H. Oncotarget. 2021;12(19):1861-1862.

    • Bice N., Kirby N., Bahr T., Rasmussen K., Saenz D., Wagner T., Papanikolaou N., Fakhreddine M. Journal of Applied Clinical Medical Physics. 2020;21(9):187-192.

    • Fakhreddine M.H., Haque W., Ahmed A., Schwartz M.R., Farach A.M., Paulino A.C., Bonefas E., Miltenburg D., Niravath P., Brian Butler E., Teh B.S. American Journal of Clinical Oncology: Cancer Clinical Trials. 2018;41(6):532-537.

    • Haque W., Verma V., Fakhreddine M., Butler E.B., Teh B.S., Simone C.B. International Journal of Radiation Oncology Biology Physics. 2018;100(2):470-477.

    • Saenz D., Astorga N., Kirby N., Fakhreddine M., Rasmussen K., Stathakis S., Papanikolaou N. Journal of Applied Clinical Medical Physics. 2018;19(5):625-631.

    • Verma V., Fakhreddine M.H., Haque W., Butler E.B., Teh B.S., Simone C.B. Radiotherapy and Oncology. 2018;128(3):492-497.

    • Fakhreddine M.H., Galvan E., Pawlowski J., Jones W.E. International Journal of Radiation Oncology Biology Physics. 2017;98(4):741-742.

    • Haque W., Verma V., Fakhreddine M., Hatch S., Butler E.B., Teh B.S. Gynecologic Oncology. 2017;144(1):28-33.

    • Ahmed A.A., Holliday E.B., Fakhreddine M., Yoo S.K., Deville C., Jagsi R. International Journal of Radiation Oncology Biology Physics. 2016;95(4):1093-1101.

    • Bhardwaj V., Cortez M.A., Fakhreddine M., Welsh J. Biological principles of radiosensitization Cancer Nanotechnology: Principles and Applications in Radiation Oncology. 2016:15-23.

    • Fakhreddine M.H., Mahajan A., Penas-Prado M., Weinberg J., McCutcheon I.E., Puduvalli V., Brown P.D. Neuro-Oncology. 2013;15(4):406-412.

    • Beal C.M., Fakhreddine M., Ezekoye O.A. Effects of leakage in simulations of positive pressure ventilation Fire Technology. 2009;45(3):257-286.